{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:52:20Z","timestamp":1790722340009,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.joms.2019.02.021","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T06:54:19Z","timestamp":1550732059000},"page":"1278.e1-1278.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-610X","authenticated-orcid":false,"given":"Pat","family":"Ricalde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Ahson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha T.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2019.02.021_bib1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1750-1172-7-S1-S6","article-title":"Cherubism: Best clinical practice","volume":"7","author":"Papadaki","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.joms.2019.02.021_bib2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jbmr.2431","article-title":"The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism: Tacrolimus for severe cherubism","volume":"30","author":"Kadlub","year":"2015","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.joms.2019.02.021_bib3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jbmr.3449","article-title":"Second-generation SYK inhibitor entospletinib ameliorates fully established inflammation and bone destruction in the cherubism mouse model","volume":"33","author":"Yoshimoto","year":"2018","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.joms.2019.02.021_bib4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jbmr.2125","article-title":"Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-\u03b1\u2013induced inflammation and bone loss","volume":"29","author":"Yoshitaka","year":"2014","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.joms.2019.02.021_bib5","first-page":"1248","volume":"9","author":"Marcucci G","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2019.02.021_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/rheumatology\/kex306","article-title":"Bone involvement in monogenic autoinflammatory syndromes","volume":"57","author":"Bader-Meunier","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.joms.2019.02.021_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1601-0825.2008.01499.x","article-title":"Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism","volume":"15","author":"Carvalho","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2019.02.021_bib8","doi-asserted-by":"crossref","first-page":"11480","DOI":"10.1038\/s41598-017-11915-5","article-title":"Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcR\u03b3-mediated phagocytosis and chemokine expression in U937 cells","volume":"7","author":"Chihara","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.joms.2019.02.021_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2016.07.019","article-title":"Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism","volume":"58","author":"Kadlub","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.joms.2019.02.021_bib10","first-page":"28","article-title":"The molecular basis of cherubism","volume":"1","year":"2012","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.joms.2019.02.021_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood-2009-08-237404","article-title":"Dysregulation of bone remodeling by imatinib mesylate","volume":"115","author":"Vandyke","year":"2010","journal-title":"Blood"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239119302332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239119302332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:58:03Z","timestamp":1759510683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239119302332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0278239119302332"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2019.02.021","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2019.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the American Association of Oral and Maxillofacial Surgeons.","name":"copyright","label":"Copyright"}]}}